Attenuation of diabetic nephropathy by tocotrienol: Involvement of NFkB signaling pathway

被引:173
作者
Kuhad, Anurag [1 ]
Chopra, Kanwaljit [1 ]
机构
[1] Panjab Univ, UGC Ctr Adv Study, Univ Inst Pharmaceut Sci, Pharmacol Res Lab, Chandigarh 160014, India
关键词
Apoptosis; Caspase-3; Diabetic nephropathy; Tocotrienol; NF kappa beta; Oxidative-nitrosative stress; TGF-beta; 1; TNF-alpha; NITRIC-OXIDE SYNTHASE; ALPHA-TOCOTRIENOL; KAPPA-B; ANTIOXIDANT PROPERTIES; GLOMERULAR INJURY; KIDNEY-DISEASE; GROWTH-FACTORS; RENAL INJURY; MOUSE MODEL; RATS;
D O I
10.1016/j.lfs.2008.12.014
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aim: Diabetic nephropathy is a serious complication for patients with diabetes mellitus. Approximately 30-40% of patients with type I and 15% with type II diabetes mellitus develop end stage renal disease. The study was designed to evaluate the impact of tocotrienol on renal function and reno-inflammatory cascade in streptozotocin-induced diabetes. Main methods: Streptozotocin (STZ)-induced diabetic rats were treated with tocotrienol (25,50 and 100 mg/kg), alpha-tocopherol (100 mg/kg) or with vehicle form 5th to 8th weeks. After 8 weeks, urine albumin excretion, urine output, serum creatinine, blood urea nitrogen, creatinine and urea clearance were measured. Cytoplasmic and nuclear fractions of kidney was prepared for the quantification of oxidative-nitrosative stress (lipid peroxidation, superoxide dismutase, catalase, non protein thiols, total nitric oxide), tumor necrosis factor-alpha (TNF-alpha), tissue growth factor-1beta (TGF-beta 1), p65 subunit of NF kappa beta and caspase-3. Key findings: After 8 weeks of STZ injection, the rats produced significant alteration in renal function, increased oxidative-nitrosative stress, TNF-alpha, TGF-beta 1, caspase-3 activity in cytoplasmic lysate and active p65 subunit of NF kappa beta in nuclear lysate of kidney of diabetic rats. Interestingly, co-administration of tocotrienol significantly and dose-dependently prevented biochemical and molecular changes associated with diabetes. Tocotrienol (100 mg/kg) was demonstrated to be more effective than alpha-tocopherol (100 mg/kg). Moreover, diabetic rats treated with insulin-tocotrienol combination produced more pronounced effect on molecular parameters as compared to their respective groups. Significance: Taken together, the data reveal that tocotrienol modulates the release of profibrotic cytokines, oxidative stress, ongoing chronic inflammation and apoptosis and thus exerts a marked renoprotective effect. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:296 / 301
页数:6
相关论文
共 55 条
[1]   γ-tocotrienol inhibits nuclear factor-κB signaling pathway through inhibition of receptor-interacting protein and TAK1 leading to suppression of antiapoptotic gene products and Potentiation of apoptosis [J].
Ahn, Kwang Seok ;
Sethi, Gautam ;
Krishnan, Koyamangalath ;
Aggarwal, Bharat B. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (01) :809-820
[2]  
ALLEN DA, 2003, J FEDERATION AM SOC, V17, P908
[3]  
Begum AN, 2002, BIOSCI BIOTECH BIOCH, V66, P398, DOI 10.1271/bbb.66.398
[4]  
BOHLE A, 1991, PATHOL RES PRACT, V187, P251
[5]   Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension [J].
Cheng, HF ;
Wang, CJ ;
Moeckel, GW ;
Zhang, MZ ;
McKanna, JA ;
Harris, RC .
KIDNEY INTERNATIONAL, 2002, 62 (03) :929-939
[6]   Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice [J].
Chow, FY ;
Nikolic-Paterson, DJ ;
Ozols, E ;
Atkins, RC ;
Rollin, BJ ;
Tesch, GH .
KIDNEY INTERNATIONAL, 2006, 69 (01) :73-80
[7]  
Claiborne A., 1985, CRC HDB METHODS OXYG, P283
[8]   THROMBOXANE IN THE PATHOGENESIS OF GLOMERULAR INJURY IN DIABETES [J].
CRAVEN, PA ;
MELHEM, MF ;
DERUBERTIS, FR .
KIDNEY INTERNATIONAL, 1992, 42 (04) :937-946
[9]   Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes [J].
DiPetrillo, K ;
Coutermarsh, B ;
Gesek, FA .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2003, 284 (01) :F113-F121
[10]   Pentoxifylline ameliorates renal tumor necrosis factor expression, sodium retention, and renal hypertrophy in diabetic rats [J].
DiPetrillo, K ;
Gesek, FA .
AMERICAN JOURNAL OF NEPHROLOGY, 2004, 24 (03) :352-359